glp 1 vs sglt2 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

28.60

★★★★☆4.8 (126)

PDF] Effects Of GLP-1 Analogues, DPP-4 Inhibitors And SGLT2 Inhibitors On The Renal System

26.79

★★★★★4.9 (98)

SGLTi and GLP-1 in HF

20.44

★★★★★5.0 (157)

SGLT2 inhibitors and GLP-1 receptor agonists can help manage #Type2Diabetes! 📉💊 🔶SGLT-2 lowers blood sugar levels by allowing more glucose to be expelled in urine. 🔷GLP-1 stabilizes blood sugar levels by boosting

22.33

★★★★★4.7 (84)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology

28.88

★★★★★4.9 (203)

Recent understandings about hypertension management in type 2 diabetes: What are the roles of SGLT2 inhibitor, GLP-1 receptor agonist, and finerenone?

25.34

★★★★★5.0 (176)

How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?

28.42

★★★★★4.8 (132)